{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:05:40Z","timestamp":1790701540632,"version":"4.1.0"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100002108","name":"Friedreich's Ataxia Research Alliance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal Plus: Cardiology Research and Practice"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ahjo.2026.100869","type":"journal-article","created":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T15:34:17Z","timestamp":1788017657000},"page":"100869","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Serial assessment of echocardiographic measures in Friedreich ataxia"],"prefix":"10.1016","volume":"70","author":[{"given":"David R.","family":"Lynch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Medina","family":"Keita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Gunther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Schadt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Mercer-Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly Y.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahjo.2026.100869_bb0005","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.2147\/JMDH.S292945","article-title":"Friedreich ataxia: multidisciplinary clinical care","volume":"14","author":"Lynch","year":"2021","journal-title":"J. Multidiscip. Healthc."},{"key":"10.1016\/j.ahjo.2026.100869_bb0010","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1056\/NEJM199610173351601","article-title":"Clinical and genetic abnormalities in patients with Friedreich\u2019s ataxia","volume":"335","author":"D\u00fcrr","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ahjo.2026.100869_bb0015","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ymgme.2007.05.009","article-title":"Advancements in the pathophysiology of Friedreich's Ataxia and new prospects for treatments","volume":"92","author":"Babady","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ahjo.2026.100869_bb0020","series-title":"GeneReviews\u00ae [Internet]","first-page":"1993","article-title":"Friedreich ataxia","author":"Bidichandani","year":"1998"},{"key":"10.1016\/j.ahjo.2026.100869_bb0025","first-page":"554","article-title":"The relationship between trinucleotide (GAA) repeat length and clinical features in Friedreich ataxia","volume":"59","author":"Filla","year":"1996","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ahjo.2026.100869_bb0030","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1212\/WNL.49.4.1153","article-title":"Very late onset Friedreich\u2019s ataxia without cardiomyopathy is associated with limited GAA expansion in the X25 gene","volume":"49","author":"Gellera","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.ahjo.2026.100869_bb0035","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1136\/hrt.81.2.141","article-title":"Marked variation in the cardiomyopathy associated with Friedreich\u2019s ataxia","volume":"81","author":"Dutka","year":"1999","journal-title":"Heart"},{"key":"10.1016\/j.ahjo.2026.100869_bb0040","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1001\/archneur.62.12.1865","article-title":"Late-onset Friedreich ataxia: phenotypic analysis, magnetic resonance imaging findings, and review of the literature","volume":"62","author":"Bhidayasiri","year":"2005","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ahjo.2026.100869_bb0045","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/mds.22864","article-title":"Analysis of the factors influencing the cardiac phenotype in Friedreich\u2019s ataxia","volume":"25","author":"Rajagopalan","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ahjo.2026.100869_bb0050","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jns.2011.05.023","article-title":"Mortality in Friedreich ataxia","volume":"307","author":"Tsou","year":"2011","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.ahjo.2026.100869_bb0055","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1002\/acn3.51352","article-title":"Scoliosis in Friedreich's ataxia: longitudinal characterization in a large heterogeneous cohort","volume":"8","author":"Rummey","year":"2021","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.ahjo.2026.100869_bb0060","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1002\/acn3.51830","article-title":"Retinal hypoplasia and degeneration result in vision loss in Friedreich ataxia","volume":"10","author":"Rodden","year":"2023","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.ahjo.2026.100869_bb0065","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00246-024-03429-5","article-title":"Characterization of cardiac-onset initial presentation in Friedreich ataxia","volume":"46","author":"Lynch","year":"2025","journal-title":"Pediatr. Cardiol."},{"key":"10.1016\/j.ahjo.2026.100869_bb0070","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1136\/archdischild-2021-322455","article-title":"Friedreich\u2019s ataxia-associated childhood hypertrophic cardiomyopathy: a national cohort study","volume":"107","author":"Norrish","year":"2022","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.ahjo.2026.100869_bb0075","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ijcard.2021.11.033","article-title":"Cellular pathophysiology of Friedreich's ataxia cardiomyopathy","volume":"346","author":"Lees","year":"2022","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ahjo.2026.100869_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0116396","article-title":"The pathogenesis of cardiomyopathy in Friedreich ataxia","volume":"10","author":"Koeppen","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ahjo.2026.100869_bb0085","doi-asserted-by":"crossref","first-page":"20590","DOI":"10.1073\/pnas.1215349109","article-title":"Identification of nonferritin mitochondrial iron deposits in a mouse model of Friedreich ataxia","volume":"109","author":"Whitnall","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ahjo.2026.100869_bb0090","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1016\/j.amjcard.2012.08.018","article-title":"Relation of cytosolic iron excess to cardiomyopathy of Friedreich\u2019s ataxia","volume":"110","author":"Ramirez","year":"2012","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ahjo.2026.100869_bb0095","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ana.10419","article-title":"Cardiac energetics correlates to myocardial hypertrophy in Friedreich\u2019s ataxia","volume":"53","author":"Bunse","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ahjo.2026.100869_bb0100","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/ana.1001","article-title":"Antioxidant treatment improves in vivo cardiac and skeletal muscle bioenergetics in patients with Friedreich\u2019s ataxia","volume":"49","author":"Lodi","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ahjo.2026.100869_bb0105","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.acvd.2021.10.010","article-title":"Characterizing cardiac phenotype in Friedreich\u2019s ataxia: the CARFA study","volume":"15","author":"Legrand","year":"2022","journal-title":"Arch. Cardiovasc. Dis."},{"key":"10.1016\/j.ahjo.2026.100869_bb0110","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/s00246-008-9305-1","article-title":"The longitudinal course of cardiomyopathy in Friedreich\u2019s ataxia during childhood","volume":"30","author":"Kipps","year":"2009","journal-title":"Pediatr. Cardiol."},{"key":"10.1016\/j.ahjo.2026.100869_bb0115","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ijcard.2015.05.074","article-title":"The cardiomyopathy in Friedreich\u2019s ataxia - new biomarker for staging cardiac involvement","volume":"194","author":"Wiedemann","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ahjo.2026.100869_bb0120","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s11845-012-0808-7","article-title":"Cardiomyopathy of Friedreich\u2019s ataxia (FRDA)","volume":"181","author":"Payne","year":"2012","journal-title":"Ir. J. Med. Sci."},{"key":"10.1016\/j.ahjo.2026.100869_bb0125","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.cardfail.2017.09.012","article-title":"The subclinical cardiomyopathy of Friedreich\u2019s ataxia in a pediatric population","volume":"24","author":"Plehn","year":"2018","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.ahjo.2026.100869_bb0130","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1586\/erc.12.57","article-title":"Management and therapy for cardiomyopathy in Friedreich\u2019s ataxia","volume":"10","author":"Lynch","year":"2012","journal-title":"Expert. Rev. Cardiovasc. Ther."},{"key":"10.1016\/j.ahjo.2026.100869_bb0135","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.amjcard.2011.09.025","article-title":"Analysis of echocardiograms in a large heterogeneous cohort of patients with Friedreich ataxia","volume":"109","author":"Regner","year":"2012","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ahjo.2026.100869_bb0140","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/j.ijcard.2012.04.159","article-title":"Elevation of serum cardiac troponin I in a cross-sectional cohort of asymptomatic subjects with Friedreich ataxia","volume":"167","author":"Friedman","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ahjo.2026.100869_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2024.123053","article-title":"Characterization of clinical serum cardiac biomarker levels in individuals with Friedreich ataxia","volume":"461","author":"Lynch","year":"2024","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.ahjo.2026.100869_bb0150","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1161\/CIRCULATIONAHA.111.059477","article-title":"The heart in Friedreich ataxia: definition of cardiomyopathy, disease severity, and correlation with neurological symptoms","volume":"125","author":"Weidemann","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.ahjo.2026.100869_bb0155","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/echo.12287","article-title":"Longitudinal strain in Friedreich ataxia: a potential marker for early left ventricular dysfunction","volume":"31","author":"St. John Sutton","year":"2014","journal-title":"Echocardiography"},{"key":"10.1016\/j.ahjo.2026.100869_bb0160","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ijcard.2021.02.032","article-title":"Prognostic value of longitudinal strain and ejection fraction in Friedreich's ataxia","volume":"330","author":"Legrand","year":"2021","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ahjo.2026.100869_bb0165","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/ejechocard\/jer267","article-title":"Normal left ventricular ejection fraction and mass but subclinical myocardial dysfunction in patients with Friedreich\u2019s ataxia","volume":"13","author":"Dedobbeleer","year":"2012","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"10.1016\/j.ahjo.2026.100869_bb0170","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/mus.28085","article-title":"Cardiopulmonary exercise testing on adaptive equipment in children and adults with Friedreich ataxia","volume":"69","author":"Cilenti","year":"2024","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ahjo.2026.100869_bb0175","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/eurheartj\/ehq443","article-title":"Impaired myocardial perfusion reserve and fibrosis in Friedreich ataxia: a mitochondrial cardiomyopathy with metabolic syndrome","volume":"32","author":"Raman","year":"2011","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ahjo.2026.100869_bb0180","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1007\/s00246-021-02675-1","article-title":"Myocardial perfusion reserve in children with Friedreich ataxia","volume":"42","author":"Hutchens","year":"2021","journal-title":"Pediatr. Cardiol."},{"key":"10.1016\/j.ahjo.2026.100869_bb0185","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/0002-8703(49)90532-3","article-title":"Myocarditis and Friedreich\u2019s ataxia; a report of two cases","volume":"38","author":"Hejtmancik","year":"1949","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ahjo.2026.100869_bb0190","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1177\/0883073812448461","article-title":"Cross-sectional analysis of electrocardiograms in a large heterogeneous cohort of Friedreich ataxia subjects","volume":"27","author":"Schadt","year":"2012","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.ahjo.2026.100869_bb0195","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.pediatrneurol.2021.01.004","article-title":"Ectopic burden via Holter monitors in Friedreich ataxia","volume":"117","author":"Mejia","year":"2021","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.ahjo.2026.100869_bb0200","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/mds.22912","article-title":"Measuring the rate of progression in Friedreich ataxia: implications for clinical trial design","volume":"25","author":"Friedman","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ahjo.2026.100869_bb0205","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/acn3.332","article-title":"Progression of Friedreich ataxia: quantitative characterization over 5 years","volume":"3","author":"Patel","year":"2016","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.ahjo.2026.100869_bb0210","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1017\/S0317167100022903","article-title":"Hypertrophic cardiomyopathy in Friedreich\u2019s ataxia: symmetric or asymmetric?","volume":"7","author":"Pasternac","year":"1980","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.ahjo.2026.100869_bb0215","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1442-200X.1996.tb03496.x","article-title":"Heart disease in Friedreich\u2019s ataxia: a clinical and echocardiographic study","volume":"38","author":"G\u00fcnal","year":"1996","journal-title":"Acta Paediatr. Jpn."},{"key":"10.1016\/j.ahjo.2026.100869_bb0220","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/brain\/104.3.589","article-title":"Friedreich's ataxia: a clinical and genetic study of 90 families with an analysis of early diagnostic criteria and intrafamilial clustering of clinical features","volume":"104","author":"Harding","year":"1981","journal-title":"Brain"},{"key":"10.1016\/j.ahjo.2026.100869_bb0225","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/mds.29687","article-title":"Predictors of survival in Friedreich\u2019s ataxia: a prospective cohort study","volume":"39","author":"Indelicato","year":"2024","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ahjo.2026.100869_bb0230","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/ana.25934","article-title":"Safety and efficacy of omaveloxolone in Friedreich ataxia (MOXIe study)","volume":"89","author":"Lynch","year":"2021","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ahjo.2026.100869_bb0235","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.ahj.2010.10.038","article-title":"Idebenone in Friedreich ataxia cardiomyopathy-results from a 6-month phase III study (IONIA)","volume":"161","author":"Lagedrost","year":"2011","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ahjo.2026.100869_bb0240","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-022-02568-3","article-title":"Clinical management guidelines for Friedreich ataxia: best practice in rare diseases","volume":"17","author":"Corben","year":"2022","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ahjo.2026.100869_bb0245","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ejpn.2007.11.006","article-title":"Idebenone treatment in paediatric and adult patients with Friedreich ataxia: long-term follow-up","volume":"12","author":"Pineda","year":"2008","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.ahjo.2026.100869_bb0250","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1080\/10715760290021333","article-title":"Heart hypertrophy and function are improved by idebenone in Friedreich\u2019s ataxia","volume":"36","author":"Rustin","year":"2002","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.ahjo.2026.100869_bb0255","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s13023-014-0184-7","article-title":"Consensus clinical management guidelines for Friedreich ataxia","volume":"9","author":"Corben","year":"2014","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ahjo.2026.100869_bb0260","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.1093\/hmg\/ddaa267","article-title":"Methylated and unmethylated epialleles support variegated epigenetic silencing in Friedreich ataxia","volume":"29","author":"Rodden","year":"2021","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ahjo.2026.100869_bb0265","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000000683","article-title":"Clinical evidence for variegated silencing in patients with Friedreich ataxia","volume":"8","author":"Rodden","year":"2022","journal-title":"Neurol. Genet."},{"key":"10.1016\/j.ahjo.2026.100869_bb0270","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/acn3.225","article-title":"Frataxin levels in peripheral tissue in Friedreich ataxia","volume":"2","author":"Lazaropoulos","year":"2015","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.ahjo.2026.100869_bb0275","doi-asserted-by":"crossref","first-page":"4251","DOI":"10.1021\/acs.analchem.3c00091","article-title":"Liquid chromatography-mass spectrometry analysis of frataxin proteoforms in whole blood as biomarkers of the genetic disease Friedreich\u2019s ataxia","volume":"95","author":"Rojsajjakul","year":"2023","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ahjo.2026.100869_bb0280","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/nm.3510","article-title":"Prevention and reversal of severe mitochondrial cardiomyopathy by gene therapy in a mouse model of Friedreich\u2019s ataxia","volume":"20","author":"Perdomini","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.ahjo.2026.100869_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2024.101193","article-title":"AAV8 gene therapy reverses cardiac pathology and prevents early mortality in a mouse model of Friedreich\u2019s ataxia","volume":"32","author":"Chang","year":"2024","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ahjo.2026.100869_bb0290","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/mus.27522","article-title":"Serum cardiac troponin I is a candidate biomarker for cardiomyopathy in Duchenne and Becker muscular dystrophies","volume":"65","author":"Yamaguchi","year":"2022","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ahjo.2026.100869_bb0295","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1038\/s41390-021-01682-5","article-title":"Duchenne muscular dystrophy patients: troponin leak in asymptomatic and implications for drug toxicity studies","volume":"92","author":"Sheybani","year":"2022","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ahjo.2026.100869_bb0300","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2021-001592","article-title":"Current state of cardiac troponin testing in Duchenne muscular dystrophy cardiomyopathy: review and recommendations from the Parent Project Muscular Dystrophy expert panel","volume":"8","author":"Spurney","year":"2021","journal-title":"Open Heart"},{"key":"10.1016\/j.ahjo.2026.100869_bb0305","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.braindev.2007.01.009","article-title":"Cardiac troponin I for accurate evaluation of cardiac status in myopathic patients","volume":"29","author":"Matsumura","year":"2007","journal-title":"Brain Dev."},{"key":"10.1016\/j.ahjo.2026.100869_bb0310","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.1002\/ehf2.14073","article-title":"Blood-based biomarkers for the prediction of hypertrophic cardiomyopathy prognosis: a systematic review and meta-analysis","volume":"9","author":"Jansen","year":"2022","journal-title":"ESC Heart Fail."},{"key":"10.1016\/j.ahjo.2026.100869_bb0315","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.2217\/bmm-2021-0022","article-title":"Alteration of serum biomarkers in patients with hypertrophic cardiomyopathy with and without atrial fibrillation","volume":"15","author":"Sari","year":"2021","journal-title":"Biomark. Med"},{"key":"10.1016\/j.ahjo.2026.100869_bb0320","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.amjcard.2021.04.040","article-title":"Usefulness of high-sensitivity cardiac troponin T to predict long-term outcome in patients with hypertrophic cardiomyopathy","volume":"152","author":"Gommans","year":"2021","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ahjo.2026.100869_bb0325","doi-asserted-by":"crossref","first-page":"4297","DOI":"10.1038\/s41598-021-83678-z","article-title":"Predictive values of multiple non-invasive markers for myocardial fibrosis in hypertrophic cardiomyopathy patients with preserved ejection fraction","volume":"11","author":"Li","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ahjo.2026.100869_bb0330","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1161\/01.CIR.102.11.1276","article-title":"Echocardiographic characterization of cardiomyopathy in Friedreich\u2019s ataxia with tissue Doppler echocardiographically derived myocardial velocity gradients","volume":"102","author":"Dutka","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ahjo.2026.100869_bb0335","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1093\/oxfordjournals.eurheartj.a060072","article-title":"Cardiomyopathy in Friedreich\u2019s ataxia: a Doppler-echocardiographic study","volume":"13","author":"Morvan","year":"1992","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ahjo.2026.100869_bb0340","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/S0735-1097(99)00396-4","article-title":"Reliability of echocardiographic assessment of left ventricular structure and function: the PRESERVE study. Prospective randomized study evaluating regression of ventricular enlargement","volume":"34","author":"Palmieri","year":"1999","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ahjo.2026.100869_bb0345","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1161\/01.CIR.104.3.310","article-title":"Reliability of multicenter pediatric echocardiographic measurements of left ventricular structure and function: the prospective P(2)C(2) HIV study","volume":"104","author":"Lipshultz","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ahjo.2026.100869_bb0350","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000000638","article-title":"Body mass index and height in the Friedreich ataxia clinical outcome measures study","volume":"7","author":"Patel","year":"2021","journal-title":"Neurol. Genet."}],"container-title":["American Heart Journal Plus: Cardiology Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666602226001588?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666602226001588?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:35:27Z","timestamp":1790699727000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666602226001588"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":70,"alternative-id":["S2666602226001588"],"URL":"https:\/\/doi.org\/10.1016\/j.ahjo.2026.100869","relation":{},"ISSN":["2666-6022"],"issn-type":[{"value":"2666-6022","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serial assessment of echocardiographic measures in Friedreich ataxia","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal Plus: Cardiology Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahjo.2026.100869","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100869"}}